Snap-on Finite-Lived Intangible Assets - Expected Amortization Expense (Year One) decreased by 11.3% to $11.80M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 0.8%, from $11.90M to $11.80M. This is a positive signal — lower values indicate better performance for this metric.
Higher values indicate a larger near-term drag on reported earnings due to previous acquisition activity.
This represents the projected non-cash expense related to the amortization of finite-lived intangible assets for the upc...
Companies with high M&A activity in the medical device space typically report significant annual amortization expenses.
finite_lived_intangible_assets_amortization_year_1| Q1 '21 | Q2 '21 | Q3 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $12.60M | $13.20M | $13.50M | $14.10M | $10.90M | $14.40M | $11.40M | $11.70M | $11.90M | $11.40M | $12.20M | $13.40M | $11.90M | $12.70M | $13.30M | $11.80M |
| QoQ Change | — | +4.8% | +2.3% | +4.4% | -22.7% | +32.1% | -20.8% | +2.6% | +1.7% | -4.2% | +7.0% | +9.8% | -11.2% | +6.7% | +4.7% | -11.3% |
| YoY Change | — | — | — | +11.9% | -17.4% | +6.7% | -19.1% | +7.3% | -17.4% | +0.0% | +4.3% | +12.6% | +4.4% | +4.1% | -0.7% | -0.8% |